FUJIFILM Holdings Co. (OTCMKTS:FUJIY) Sees Significant Growth in Short Interest

FUJIFILM Holdings Co. (OTCMKTS:FUJIY) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 126,500 shares, an increase of 86.3% from the August 15th total of 67,900 shares. Based on an average daily trading volume, of 112,600 shares, the short-interest ratio is currently 1.1 days.

FUJIFILM Stock Performance

OTCMKTS FUJIY traded down $0.25 during trading hours on Friday, reaching $13.40. 39,960 shares of the company were exchanged, compared to its average volume of 90,864. FUJIFILM has a 1 year low of $8.99 and a 1 year high of $13.88. The business’s 50 day simple moving average is $12.22 and its 200-day simple moving average is $11.43. The company has a quick ratio of 0.82, a current ratio of 1.29 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $33.34 billion, a P/E ratio of 18.87, a P/E/G ratio of 2.49 and a beta of 0.43.

FUJIFILM (OTCMKTS:FUJIY) last issued its earnings results on Wednesday, August 7th. The technology company reported $0.16 earnings per share for the quarter. The firm had revenue of $4.80 billion during the quarter. FUJIFILM had a net margin of 8.19% and a return on equity of 7.96%. On average, equities research analysts expect that FUJIFILM will post 0.7 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded shares of FUJIFILM from a “hold” rating to a “buy” rating in a report on Tuesday, August 20th.

About FUJIFILM

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.